Browsing publications by Dr Martin Highley

Newcastle AuthorsTitleYearFull text
Professor Ruth Plummer
Dr Andrew Hughes
Dr Martin Highley
Dr Sathyarathna Gokul
Professor Alan Calvert
et al.
A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor2003
Huw Thomas
Mike Cole
Suzanne Elliott
Professor Herbie Newell
Professor Alan Calvert
et al.
Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide2002
Professor Alan Boddy
Dr Martin Highley
Dr John Fenwick
Professor Alan Calvert
Estimation of glomerular filtration rate in cancer patients2001
Professor Alan Boddy
Melanie Griffin
Julieann Sludden
Huw Thomas
Kevin Fishwick
et al.
Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer2001
Professor Alan Boddy
Melanie Griffin
Julieann Sludden
Huw Thomas
Kevin Fishwick
et al.
Paclitaxel and carboplatin dose-intensity and duration of infusion in the treatment of ovarian cancer2000
Professor Alan Calvert
Dr Martin Highley
Professor John Lunec
Professor Alan Boddy
Carboplatin and paclitaxel, alone and in combination: Dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene1999
Dr Martin Highley
Intravesical drug delivery - Pharmacokinetic and clinical considerations1999
Dr Martin Highley
Pharmacokinetics and bioavailability of oral 5 '-deoxy-5-fluorouridine in cancer patients1999
Dr Martin Highley
Professor Ruth Plummer
Phase I study of BMS-184476, a new taxane analog, given weekly in patients with advanced malignancies1999
Professor Ruth Plummer
Professor Alan Calvert
Dr Martin Highley
Phase I trial of ZD9331 in adult patients with refractory solid malignancies administered by 30-min infusion on days 1 and 8 with the cycle repeated every 3 weeks1999